AAAAAA

   
Results: 1-10 |
Results: 10
HIGH-INCIDENCE OF CRYPTIC TRANSLOCATIONS INVOLVING THE IG HEAVY-CHAINGENE IN MULTIPLE-MYELOMA, AS SHOWN BY FLUORESCENCE IN-SITU HYBRIDIZATION
Authors: AVETLOISEAU H BRIGAUDEAU C MORINEAU N TALMANT P LAI JL DAVIET A LI JY PRALORAN V RAPP MJ HAROUSSEAU JL FACON T BATAILLE R
Citation: H. Avetloiseau et al., HIGH-INCIDENCE OF CRYPTIC TRANSLOCATIONS INVOLVING THE IG HEAVY-CHAINGENE IN MULTIPLE-MYELOMA, AS SHOWN BY FLUORESCENCE IN-SITU HYBRIDIZATION, Genes chromosomes & cancer (Print), 24(1), 1999, pp. 9-15
EARLY INTENSIVE THERAPY WITH AUTOLOGOUS STEM-CELL TRANSPLANTATION IN HIGH-RISK HODGKINS-DISEASE - LONG-TERM FOLLOW-UP IN 35 CASES
Authors: MOREAU P MILPIED N RAPP MJ MOREAU A BOURDIN S MAHE MA DUPAS B LETORTOREC S HAMIDOU M MAISONEUVE H MAHE S BULABOIS CE MORINEAU N JARDEL H HAROUSSEAU JL
Citation: P. Moreau et al., EARLY INTENSIVE THERAPY WITH AUTOLOGOUS STEM-CELL TRANSPLANTATION IN HIGH-RISK HODGKINS-DISEASE - LONG-TERM FOLLOW-UP IN 35 CASES, Leukemia & lymphoma, 30(3-4), 1998, pp. 313-324
HIGH-DOSE THERAPY WITH STEM-CELL TRANSPLANTATION FOR MANTLE CELL LYMPHOMA - RESULTS AND PROGNOSTIC FACTORS, A SINGLE-CENTER EXPERIENCE
Authors: MILPIED N GAILLARD F MOREAU P MAHE B SOUCHET J RAPP MJ BULABOIS CE MORINEAU N HAROUSSEAU JL
Citation: N. Milpied et al., HIGH-DOSE THERAPY WITH STEM-CELL TRANSPLANTATION FOR MANTLE CELL LYMPHOMA - RESULTS AND PROGNOSTIC FACTORS, A SINGLE-CENTER EXPERIENCE, Bone marrow transplantation, 22(7), 1998, pp. 645-650
PURGED OR UNPURGED AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) FOR 66PATIENTS (PTS) WITH FOLLICULAR LYMPHOMAS (FL) - A SINGLE-CENTER EXPERIENCE
Authors: BULABOIS CE MILPIED N MAHE B MORINEAU N MOREAU P MELLERIN MP DECERVENS C MOREAU A HAROUSSEAU JL
Citation: Ce. Bulabois et al., PURGED OR UNPURGED AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) FOR 66PATIENTS (PTS) WITH FOLLICULAR LYMPHOMAS (FL) - A SINGLE-CENTER EXPERIENCE, Bone marrow transplantation, 21, 1998, pp. 582-582
HIGH-DOSE THERAPY (HDT) WITH STEM-CELL TRANSPLANTATION (BMT) FOR MANTLE CELL LYMPHOMA (MCL) - RESULTS AND PROGNOSTIC FACTORS - A SINGLE-CENTER EXPERIENCE
Authors: MILPIED N GAILLARD F MOREAU P MAHE B SOUCHET J RAPP MJ BULABOIS CE MORINEAU N HAROUSSEAU JL
Citation: N. Milpied et al., HIGH-DOSE THERAPY (HDT) WITH STEM-CELL TRANSPLANTATION (BMT) FOR MANTLE CELL LYMPHOMA (MCL) - RESULTS AND PROGNOSTIC FACTORS - A SINGLE-CENTER EXPERIENCE, Bone marrow transplantation, 21, 1998, pp. 596-596
PILOT-STUDY OF 220 MG M2 MELPHALAN (HDM 220) FOLLOWED BY AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) IN 22 PATIENTS WITH ADVANCED MULTIPLE-MYELOMA (MM)
Authors: MOREAU P MILPIED N KERGUERIS MF BULABOIS CE MORINEAU N RAPP MJ MAHE B BATAILLE R HAROUSSEAU JL
Citation: P. Moreau et al., PILOT-STUDY OF 220 MG M2 MELPHALAN (HDM 220) FOLLOWED BY AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) IN 22 PATIENTS WITH ADVANCED MULTIPLE-MYELOMA (MM), Bone marrow transplantation, 21, 1998, pp. 715-715
MYELOABLATIVE THERAPY WITH STEM-CELL SUPPORT (BMT) IS FEASIBLE AND EFFECTIVE IN MANTLE CELL LYMPHOMA (MCL) - A SINGLE-CENTER EXPERIENCE OVER 5 YEARS
Authors: MILPIED N GAILLARD F MOREAU P SOUCHET J MAHE B RAPP MJ BULABOIS CE MORINEAU N HAROUSSEAU JL
Citation: N. Milpied et al., MYELOABLATIVE THERAPY WITH STEM-CELL SUPPORT (BMT) IS FEASIBLE AND EFFECTIVE IN MANTLE CELL LYMPHOMA (MCL) - A SINGLE-CENTER EXPERIENCE OVER 5 YEARS, Experimental hematology, 25(8), 1997, pp. 18-18
PURGED OR UNPURGED AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) FOR 66PATIENTS (PTS) WITH FOLLICULAR LYMPHOMAS (FL) - A SINGLE-CENTER EXPERIENCE
Authors: BULABOIS CE MILPIED N MAHE B MORINEAU N MOREAU P MELLERIN MP DECERVENS C MOREAU A HAROUSSEAU JL
Citation: Ce. Bulabois et al., PURGED OR UNPURGED AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) FOR 66PATIENTS (PTS) WITH FOLLICULAR LYMPHOMAS (FL) - A SINGLE-CENTER EXPERIENCE, Blood, 90(10), 1997, pp. 4548-4548
HIGH-DOSE THERAPY (HDT) WITH STEM-CELL TRANSPLANTATION (BMT) FOR MANTLE CELL LYMPHOMA (MCL) - RESULTS AND PROGNOSTIC FACTORS - A SINGLE-CENTER EXPERIENCE
Authors: MILPIED N GAILLARD F MOREAU P MAHE B SOUCHET J RAPP MJ BULABOIS CE MORINEAU N HAROUSSEAU JL
Citation: N. Milpied et al., HIGH-DOSE THERAPY (HDT) WITH STEM-CELL TRANSPLANTATION (BMT) FOR MANTLE CELL LYMPHOMA (MCL) - RESULTS AND PROGNOSTIC FACTORS - A SINGLE-CENTER EXPERIENCE, Blood, 90(10), 1997, pp. 1693-1693
PILOT-STUDY OF 220 MG M(2) MELPHALAN (HDM-220) FOLLOWED BY AUTOLOGOUSSTEM-CELL TRANSPLANTATION (ASCT) IN 22 PATIENTS WITH ADVANCED MULTIPLE-MYELOMA (MM)/
Authors: MOREAU P MILPIED N KERGUERIS MF BULABOIS CE MORINEAU N RAPP MJ MAHE B BATAILLE R HAROUSSEAU JL
Citation: P. Moreau et al., PILOT-STUDY OF 220 MG M(2) MELPHALAN (HDM-220) FOLLOWED BY AUTOLOGOUSSTEM-CELL TRANSPLANTATION (ASCT) IN 22 PATIENTS WITH ADVANCED MULTIPLE-MYELOMA (MM)/, Blood, 90(10), 1997, pp. 1708-1708
Risultati: 1-10 |